CareDx Appoints John W. Hanna as New CEO and Board Member
Company Announcements

CareDx Appoints John W. Hanna as New CEO and Board Member

CareDx (CDNA) just unveiled an announcement.

CareDx, Inc. has announced that John W. Hanna will take the helm as President and CEO starting April 15, 2024, as well as joining the Board as a Class III director. Hanna brings a wealth of experience from his previous CEO role at Apton Biosystems and leadership positions at both Veracyte, Inc., and Pacific Biosciences. His new compensation package includes an initial annual salary of $675,000 with the potential for a 100% performance bonus, and equity incentives valued at $8 million that vest over time. Hanna’s appointment coincides with the dissolution of the Company’s Office of the Chief Executive Officer, with previous members assuming other executive roles within the company.

For a thorough assessment of CDNA stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyCareDx price target lowered to $35 from $40 at BTIG
TipRanks Auto-Generated NewsdeskCareDx Inc. Reports Solid Growth and Raises Guidance
TheFlyCareDx reports Q3 EPS 14c, consensus 1c
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App